Tuesday, March 31, 2020

The timetable for a coronavirus vaccine is 18 months. Experts say that's risky

Eighteen months might sound like a long time, but in vaccine years, it's a blink. That's the long end of the Trump administration's time window for developing a coronavirus vaccine, and some leaders in the field say this is too fast -- and could come at the expense of safety. CNN 

FDA OKs Addition To Stockpile Of Malaria Drugs For COVID-19

Over the weekend, the Food and Drug Administration granted two malaria drugs "emergency use authorization" for the treatment of COVID-19. The move makes it easier to add the medicines to the strategic stockpile, which can be drawn upon in the current public health emergency.npr

Can Antimalarial Drugs Really Stop COVID-19? We Just Don’t Know Yet.

But safe and effective treatment of COVID-19 isn’t as simple as handing out medication currently available. Doctors can prescribe drugs to treat illnesses other than the ones they were approved for, and many may already be doing that to fight this disease. But experts say that’s a risky and unreliable way to combat the pandemic, and it may cause more harm than good. FiveThirtyEight

These companies are racing to roll out COVID-19 treatments

Several high profile companies are working on new experimental vaccines. Drug giant Johnson & Johnson (JNJ) is the latest to announce a promising vaccine candidate, saying on Monday that it plans human testing by September with the hopes of having more than one billion doses of a vaccine available for emergency use by early 2021.CNN Business 

Monday, March 30, 2020

covid-19: why we should all wear masks — there is new Scientific rational

Since the CDC provides no scientific evidence for its statement that masks worn by the public “are not effective”, here we review the scientific support for protection conferred by surgical masks. Medium

‘Anti-malaria drug can kill coronavirus’: Novartis chief

Swiss pharmaceutical giant Novartis believes the anti-malaria drug hydroxychloroquine offers one of the best hopes to combat coronavirus and has donated 130 million doses as part of the pandemic response.Swissinfo

An experimental peptide could block Covid-19

In hopes of developing a possible treatment for Covid-19, a team of MIT chemists has designed a drug candidate that they believe may block coronaviruses’ ability to enter human cells. The potential drug is a short protein fragment, or peptide, that mimics a protein found on the surface of human cells. MITNews 

MIT Will Post Free Plans Online for an Emergency Ventilator That Can Be Built for $100

One of the most pressing shortages facing hospitals during the Covid-19 emergency is a lack of ventilators. These machines can keep patients breathing when they no longer can on their own, and they can cost around $30,000 each. Now, a rapidly assembled volunteer team of engineers, physicians, computer scientists, and others, centered at MIT, is working to implement a safe, inexpensive alternative for emergency use, which could be built quickly around the world. SciTechDaily 

Dr. Vladimir Zelenko has now treated 699 coronavirus patients with 100% success

In an exclusive interview with former New York Mayor, Rudy Giuliani, Dr. Vladmir Zelenko shares the results of his latest study, which showed that out of his 699 patients treated, zero patients died, zero patients intubated, and four hospitalizations. TechStarUp 

Thursday, March 26, 2020

Potential COVID-19 therapeutics currently in development

As the world rushes to identify the best coronavirus treatments and vaccines, John Cahill rounds up the latest developments in potential COVID-19 therapies.EPR

Gilead made a remarkable request of the FDA in regard to its coronavirus drug

Remdesivir, the experimental COVID-19 treatment from Gilead, has been one of the drugs thought to have the most potential to treat the novel coronavirus. It's already been deployed in the U.S. and multiple other countries as this pandemic spreads. Fortune

'We've stepped up': Manitoba researchers begin clinical trial with drug they hope can help in COVID-19 fight

Dr. Ryan Zarychanski, an associate professor of internal medicine, said preliminary studies have suggested hydroxychloroquine — a drug approved by Health Canada to prevent and treat malaria since the 1950s — can be repurposed to reduce the severity of COVID-19. CBC

Tuesday, March 24, 2020

Amazon will deliver and pick up at-home test kits provided by new coronavirus program in Seattle

Amazon Care, the arm of Amazon providing medical care to employees, is helping with the delivery and logistics. It will deliver tests to people who either feel sick or are asymptomatic. Amazon Care will pick them up for analysis. If the coronavirus is detected in swabs, the participant will be contacted by a health-care worker. CNBC News 

New York will be first state to test treatment of coronavirus with blood from recovered patients

Hoping to stem the toll of the state’s surging coronavirus outbreak, New York health officials plan to begin collecting plasma from people who have recovered and injecting the antibody-rich fluid into patients still fighting the virus. Gov. Andrew Cuomo announced the plans during a news briefing Monday. The treatment, known as convalescent plasma, dates back centuries and was used during the flu epidemic of 1918 — in an era before modern vaccines and antiviral drugs. NBC News 

Monday, March 23, 2020

Regeneron to treat coronavirus patients this week in trial using its rheumatoid arthritis drug

Regeneron Pharmaceuticals this week initiated test trials of an arthritis drug as a potential remedy for the worst symptoms of COVID-19 in hopes of confirming studies in China. CNBC

FDA Approves New Rapid Coronavirus Test That Can Give Results In 45 Minutes

Would you rather have COVID-19 causing coronavirus test results in 45 minutes or a few days?
 If your answer is 45 minutes then you may be happy to see a new U.S. Food and Drug Administration (FDA) announcement about a new rapid test. But don’t rapidly jump to conclusions just yet before you hear of the details behind this emergency use authorization (EUA) approval. FORBES 

There's drug combo to shorten coronavirus, French researchers say

Researchers in France have issued a statement detailing how a combination of antimalarial medication and antibiotics could be a vital weapon in the battle against coronavirus. FoxNews 

Scientists Identify 69 Drugs to Test Against the Coronavirus

Nearly 70 drugs and experimental compounds may be effective in treating the coronavirus, a team of researchers reported on Sunday night. NYT

Sunday, March 22, 2020

Follow Five Steps to Wash Your Hands the Right Way

Follow Five Steps to Wash Your Hands the Right Way-> Video 

WHO officials say at least 20 coronavirus vaccines are in development in global race for cure

“The acceleration of this process is really truly dramatic in terms of what we’re able to do, building on work that started with SARS, that started with MERS and now is being used for COVID-19 ,” Dr. Maria Van Kerkhove, the technical lead for WHO’s emergencies program, said at a press conference at the organization’s headquarters in Geneva on Friday.CNBC

Israeli scientists: 'In a few weeks, we will have coronavirus vaccine'

Once the vaccine is developed, it will take at least 90 days to complete the regulatory process and potentially more to enter the marketplace. The Jerusalem Post 

New coronavirus test returns results in 45 minutes, but it may be limited to hospitals

A new diagnostic test for the novel coronavirus will return results in just 45 minutes, four times faster than existing machines. STAT

Coronavirus drugs: Where we are and what we know


Malaria, HIV and arthritis wouldn’t seem to have much in common with SARS-CoV-2, the novel coronavirus that has upended the world in just a few short months. But medicines developed for those ailments are showing some promise against the respiratory illness at the center of the pandemic. Los Angeles Times